PL405262A1 - Pharmaceutical composition, containing dokozahexaenic acid and its application - Google Patents

Pharmaceutical composition, containing dokozahexaenic acid and its application

Info

Publication number
PL405262A1
PL405262A1 PL405262A PL40526213A PL405262A1 PL 405262 A1 PL405262 A1 PL 405262A1 PL 405262 A PL405262 A PL 405262A PL 40526213 A PL40526213 A PL 40526213A PL 405262 A1 PL405262 A1 PL 405262A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
acid
dokozahexaenic
application
risk
Prior art date
Application number
PL405262A
Other languages
Polish (pl)
Other versions
PL232034B1 (en
Inventor
Jarosław Wypych
Aneta Pakieła-Rajtkowska
Original Assignee
Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sequoia Spółka Z Ograniczoną Odpowiedzialnością filed Critical Sequoia Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL405262A priority Critical patent/PL232034B1/en
Publication of PL405262A1 publication Critical patent/PL405262A1/en
Publication of PL232034B1 publication Critical patent/PL232034B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Przedmiotem wynalazku jest kwas dokozaheksaenowy, który można stosować w zmniejszaniu ryzyka przedwczesnego porodu. Kwas dokozaheksaenowy jest pochodzenia naturalnego, pozyskany został z alg naturalnych. Przedmiotem wynalazku jest również kompozycja farmaceutyczna w postaci kapsułki do stosowania w zmniejszaniu ryzyka przedwczesnego porodu. The present invention relates to docosahexaenoic acid which can be used to reduce the risk of premature delivery. Docosahexaenoic acid is of natural origin, obtained from natural algae. The invention also relates to a pharmaceutical composition in the form of a capsule for use in reducing the risk of premature delivery.

PL405262A 2013-09-06 2013-09-06 Pharmaceutical composition, containing dokozahexaenic acid and its application PL232034B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL405262A PL232034B1 (en) 2013-09-06 2013-09-06 Pharmaceutical composition, containing dokozahexaenic acid and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL405262A PL232034B1 (en) 2013-09-06 2013-09-06 Pharmaceutical composition, containing dokozahexaenic acid and its application

Publications (2)

Publication Number Publication Date
PL405262A1 true PL405262A1 (en) 2015-03-16
PL232034B1 PL232034B1 (en) 2019-05-31

Family

ID=52633776

Family Applications (1)

Application Number Title Priority Date Filing Date
PL405262A PL232034B1 (en) 2013-09-06 2013-09-06 Pharmaceutical composition, containing dokozahexaenic acid and its application

Country Status (1)

Country Link
PL (1) PL232034B1 (en)

Also Published As

Publication number Publication date
PL232034B1 (en) 2019-05-31

Similar Documents

Publication Publication Date Title
CL2017000969A1 (en) Compositions of factor viii and methods for making and using them (divisional application no. 2166-2014)
CL2016000882A1 (en) Compositions of arni against component c5 of the complement and methods for its use (divisional sol. No. 2710-15).
EA201890239A2 (en) FUMARATES AS A DEVELOPMENT AND THEIR APPLICATION IN THE TREATMENT OF DIFFERENT DISEASES
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201591003A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
JO3773B1 (en) P2x7 modulators
EA201791717A1 (en) STABLE WATER COMPOSITIONS ADALIMUMAB
AR089931A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYLFUMARATE
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
ECSP12012167A (en) Procedures for the formation of cyclodextrin complexes to formulate peptide proteasome inhibitors
UA116239C2 (en) Novel pyridine derivatives
IN2012DE00912A (en)
MX2015011767A (en) Compositions of crude algal oil.
MX340147B (en) Pharmaceutical and nutraceutical compositions of abscisic acid.
UA116889C2 (en) COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS
EA201592085A1 (en) APPLICATION OF FATTY ACID OF TALL OIL
MX370990B (en) Esters of oligo-hydroxycarboxylic acids and use thereof.
EA201500821A1 (en) Derivatives of 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purines, their use as pharmaceuticals and pharmaceutical compounds
MX2016000294A (en) Pharmaceutical composition for a sustained release of lanreotide.
MY172557A (en) Compositions for the treatment of hypertension and/or fibrosis
MX2015012318A (en) Solid state forms of a quinazoline derivative and its use as a braf inhibitor.
MX366651B (en) Crystal form alpha of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same.
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
PH12016501117A1 (en) Pharmaceutical compositions of carotenoid
JO3688B1 (en) Pharmaceutical composition in the form of an oral suspension comprising a flavonoid fraction and xanthan gum